(A) Representative images of S1pr3 immunofluorescence staining (upper panel, scale bar = 50 μm), HE staining (middle panel, scale bar = 100 μm), and ... p < 0.0001. Pulmonary fibrosis (PF ...
News-Medical.Net on MSN8d
Blocking Piezo2 may offer a new therapeutic approach for pulmonary fibrotic diseasesResearchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...
Pliant Therapeutics has discontinued a phase 2b/3 trial after recording at least a 7% higher rate of adverse events tied to idiopathic pulmonary fibrosis (IPF) in the treatment arms compared to ...
Researchers reveal critical mechanism behind idiopathic pulmonary fibrosis. Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease ...
The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...
The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback